Xcopri Maintenance Pack 100 Mg, 150 Mg
NDC Package 83114-101-56

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Xcopri Maintenance Pack 100 Mg, 150 Mg is a . Marketed by Pci Pharma Services Canada, Inc., this product is identified by NDC 83114-101 and is authorized under FDA application NDA212839.

Identification & Billing

NDC Package Code
83114-101-56
Package Description
1 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
83114-101
11-Digit Billing Format
83114010156

Clinical Specifications

Proprietary Name
Xcopri Maintenance Pack 100 Mg, 150 Mg
Dosage Form
-

Regulatory & Marketing

Labeler Name
Pci Pharma Services Canada, Inc.
FDA Application #
NDA212839
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-12-2020
End Marketing Date
03-12-2020
Listing Expiration
03-12-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83114-101-56 identifies a specific commercial package of 1 tablet, film coated in 1 blister pack of Xcopri Maintenance Pack 100 Mg, 150 Mg, labeled by Pci Pharma Services Canada, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pci Pharma Services Canada, Inc. on March 12, 2020. The current certification is valid through March 12, 2020.

How is this Pci Pharma Services Canada, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83114010156. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83114-101-56
11-Digit CMS (5-4-2)
83114-0101-56

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.